StockData
ProQR Therapeutics N.V. logo

ProQR Therapeutics N.V. (PRQR) stock

PRQRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 7/30
$1.15−0.03 (-2.54%)

Close on Nov 17, 2026Market cap $121.17MP/E –Yield –

ProQR Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

ProQR Therapeutics's enterprise value was $9.15M on Nov 11, 2026, against $124.60M a year earlier. Over the last 5 years it ranged from -$107.29M to $315.83M, with a median of $49.61M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$9.15M-89.8%
2025Dec 31, 2025$89.98M-29.8%
2024Dec 31, 2024$128.19M+349.7%
2023Dec 29, 2023$28.50M-82.5%
2022Dec 30, 2022$163.21M-48.3%
2021Dec 31, 2021$315.83M+164.4%
2020Dec 31, 2020$119.44M-66.4%
2019Dec 31, 2019$355.23M-34.9%
2018Dec 31, 2018$546.05M+4876.6%
2017Dec 29, 2017$10.97M-23.2%
2016Dec 30, 2016$14.28M–

More ProQR Therapeutics figures

See a number that looks wrong?